Alzheimer Disease - Blood
Research News and Information

Monday, November 23, 2009

High serum Abeta and vascular risk factors in first-degree relatives of Alzheimer's disease patients.

6 Dec 2009 The main objective of this study was to determine whether elevated blood beta-amyloid (Abeta) levels among the first-degree relatives of patients with Alzheimer's Disease (AD) are associated with vascular risk factors of AD. Serum Abeta was measured ... Read more...

Polyunsaturated fatty acid status in attention deficit hyperactivity disorder, depression, and Alzheimer's disease: towards an omega-3 index for mental health?

29 Sep 2009 Interest in the role of polyunsaturated fatty acids (PUFAs), particularly long-chain (LC) omega-3 (n-3) PUFAs, in mental health is increasing. This review investigates whether n-3 PUFA levels are abnormal in people with three prevalent mental health ... Read more...

Parental history of Alzheimer disease associated with lower plasma apolipoprotein E levels.

30 Aug 2009 BACKGROUND: Variation in APOE genotype is a determinant of Alzheimer disease (AD), but the risk associated with variation in plasma apoE levels has yet to be determined. Here, we studied offspring with and without a parental history of AD to ... Read more...

Latest indexed articles for 'Alzheimer Disease - Blood'

These are the very latest articles for this heading:

• High serum Abeta and vascular risk factors in first-degree relatives of Alzheimer's disease patients. 6 Dec 2009
• Polyunsaturated fatty acid status in attention deficit hyperactivity disorder, depression, and Alzheimer's disease: towards an omega-3 index for mental health? 29 Sep 2009
• Parental history of Alzheimer disease associated with lower plasma apolipoprotein E levels. 30 Aug 2009
• An update on treatment and prevention strategies for Alzheimer's disease. 30 Aug 2009
• Midlife serum cholesterol and increased risk of Alzheimer's and vascular dementia three decades later. 2 Aug 2009
• Decreased serum lipids in patients with probable Alzheimer's disease. 30 Jul 2009
• Progression of mild cognitive impairment to Alzheimer's disease: improved diagnostic value of the combined use of N200 latency and beta-amyloid(1-42) levels. 21 Jul 2009
• Influence of the Pro12Ala polymorphism of PPAR-gamma on age at onset and sRAGE levels in Alzheimer's disease. 21 Jul 2009
• Platelet serotonin concentration and monoamine oxidase type B activity in female patients in early, middle and late phase of Alzheimer's disease. 10 Jul 2009
• Strategies for the generation of parametric images of [11C]PIB with plasma input functions considering discriminations and reproducibility. 6 Jul 2009
• Neuroprotective natural antibodies to assemblies of amyloidogenic peptides decrease with normal aging and advancing Alzheimer's disease. 4 Jul 2009
• Association between mid-life marital status and cognitive function in later life: population based cohort study. 30 Jun 2009
• Elevated serum pesticide levels and risk of Parkinson disease. 29 Jun 2009
• Elevated basal cortisol level predicts lower hippocampal volume and cognitive decline in Alzheimer's disease. 28 Jun 2009
• Plasma levels of 24S-hydroxycholesterol reflect brain volumes in patients without objective cognitive impairment but not in those with Alzheimer's disease. 24 Jun 2009
• Alterations in lymphocyte subset patterns and co-stimulatory molecules in patients with Alzheimer disease. 18 Jun 2009
• B-type natriuretic peptide plasma levels are elevated in subcortical vascular dementia. 15 Jun 2009
• Enrichment and analysis of Alzheimer's Abeta1-42 peptide in human plasma and whole blood. 7 Jun 2009
• The effect of therapeutic touch on behavioral symptoms and cortisol in persons with dementia. 3 Jun 2009
• The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease. 25 May 2009

See a longer list of these articles.

Technical information about 'Alzheimer Disease'

Definition: A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)

Descriptor UI: D000544

Alternative terms: Alzheimer Disease; Disease, Alzheimer; Dementia, Senile; Dementias, Senile; Senile Dementia; Senile Dementias; Dementia, Primary Senile Degenerative; Senile Dementia, Alzheimer Type; Alzheimer Type Senile Dementia; Primary Senile Degenerative Dementia; Alzheimer's Disease; Disease, Alzheimer's; Dementia, Alzheimer Type; Alzheimer Type Dementia; Dementia, Presenile; Dementias, Presenile; Presenile Dementia; Presenile Dementias; Alzheimer Disease, Late Onset; Late Onset Alzheimer Disease; Alzheimer's Disease, Focal Onset; Focal Onset Alzheimer's Disease; Acute Confusional Senile Dementia; Senile Dementia, Acute Confusional; Alzheimer Disease, Early Onset; Early Onset Alzheimer Disease; Presenile Alzheimer Dementia; Alzheimer Dementia, Presenile; Dementia, Presenile Alzheimer;

Related Mesh Headings: Amyloid beta-Protein; Amyloid beta-Protein Precursor; Cerebral Amyloid Angiopathy; tau Proteins; Neurofilament Proteins; Aphasia, Primary Progressive; Kluver-Bucy Syndrome;

Allowable Qualifiers: blood; cerebrospinal fluid; chemically induced; classification; complications; congenital; diagnosis; diet therapy; drug therapy; economics; embryology; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; radiotherapy; rehabilitation; surgery; therapy; urine; veterinary; ultrasonography; virology;

Tree Number: C10.228.140.380.100; C10.574.945.249; F03.087.400.100;

History Note: 1998(1963); for DEMENTIA, PRESENILE and DEMENTIA, PRIMARY DEGENERATIVE SENILE use DEMENTIA 1981-1999; for DEMENTIA SENILE use DEMENTIA 1966-1999